3413 results for «2025»

Filter By

3413 results

iFR versus angiography-guided CABG: 3-year results of the iCABG randomised trial

31 Oct 2025

Alex Sticchi provides his take on the iCABG trial presented by Rasa Ordiene at TCT 2025, in San Francisco.

Alessandro Sticchi

Author

Alessandro Sticchi
iFR versus angiography-guided CABG: 3-year results of the iCABG randomized trial

OPTION-STEMI: Immediate versus staged complete revascularisation during index admission in patients with STEMI and multivessel disease

02 Sep 2025

Mirvat Alasnag provides her take on OPTION-STEMI, presented by Youngkeun Ahn at ESC Congress 2025 in Madrid.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
OPTION STEMI - Immediate vs staged complete revascularisation during index admission in patients with STEMI & MVD

The effectiveness and safety of a planned investment procedure in high-risk chronic total occlusions - The INVEST CTO single arm study

03 Nov 2025

Kalaivani Mahadevan and Sofia Papadopoulou provide their take on the INVEST CTO trial, presented by Anja Oksnes at TCT 2025, in San Francisco.

Kalaivani Mahadevan

Author

Kalaivani Mahadevan
Sofia Papadopoulou

Author

Sofia Papadopoulou
INVEST-CTO: Single arm study of a planned investment procedure in high-risk CTO PCI

OCT insights of thrombus extraction by stent-retriever thrombectomy (SRT) and manual aspiration (MA): Insights from RETRIEVE AMI trial

29 Oct 2025

Aaysha Cader provides her take on sub-analyses of the RETRIEVE AMI trial presented by Jason Leo Walsh at TCT 2025, in San Francisco.

Author

Aaysha Cader
RETRIEVE AMI: OCT insights of SRT and MA

PCRonline @ ACC.25 Scientific Sessions

07 Feb 2025

Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2025 Scientific Sessions #ACC25

PCRonline @ ACC.25 Scientific Sessions

Long-term follow-up of the PARTNER 3 Low-Risk randomised trial: seven-year clinical and echocardiographic outcomes

27 Oct 2025

Mirvat Alasnag interviews Michael J. Mack on the PARTNER 3 Low-Risk randomised trial he presented at TCT 2025 in San Francisco.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Michael Mack

Author

Michael Mack
Long-term follow-up of the PARTNER 3 Low-Risk randomised trial: seven-year clinical and echocardiographic outcomes

TAILORED-CHIP: Tailored antiplatelet therapy for complex high-risk PCI

29 Aug 2025

Nicola Ryan provides her take on the results of TAILORED-CHIP presented by Duk-Woo Park at the ESC Congress 2025 in Madrid.

Nicola Ryan

Author

Nicola Ryan
TAILORED-CHIP: Tailored Antiplatelet Therapy for Complex High-Risk PCI

Academic Research Consortium initiative on left atrial appendage closure – standardising definitions and endpoints to move forward

21 May 2025

Philippe Garot describes the EuroPCR 2025 session on left atrial appendage closure (LAAC), which offers a preview of the upcoming new consensus document developed by the Academic Research Consortium.

Dr Philippe Garot

Author

Philippe Garot
Academic Research Consortium initiative on left atrial appendage closure – standardising definitions and endpoints to move forward

PCR: a home for everyone in the field of interventional cardiology

12 Oct 2025

In July 2025, a unilateral decision of the ESC closed a chapter on nearly two decades of successful collaboration between ESC-EAPCI and PCR-Europa - a partnership first established in 2006 and most recently renewed in 2023. 

PCR

SWEDEHEART: Improving the quality of cardiology care in Sweden and beyond!

22 May 2025

Lars Wallentin and Stefan James received the Andreas Grüntzig Ethica Award during EuroPCR 2025, on behalf of a wider team of cardiovascular registry experts who have contributed in an extraordinary way to the PCR mission. 

Improving the quality of cardiology care in Sweden and beyond!

How to manage the challenges of TAVI in bicuspid disease?

22 May 2025 – From EuroPCR 2025

How should TAVI be adapted to the unique challenges of bicuspid aortic valve disease? In this EuroPCR 2025 discussion, Chiara De Biase, Kentaro Hayashida, and Didier Tchetche explore the key anatomical and procedural considerations for tailoring treatment. From selecting which bicuspid anatomies are suitable for TAVI...

How to manage the challenges of TAVI in bicuspid disease?

Redefining complex PCI: impact of real-world data and novel evidence on IV antithrombotic strategies

21 May 2025 – From EuroPCR 2025

Explore how real-world data and evolving evidence are reshaping IV antithrombotic strategies in complex PCI. This EuroPCR 2025 session brings together urgent clinical cases—including STEMI patients in shock—and highlights key insights from the SMILE registry. Learn how transition protocols from cangrelor to oral P2Y12 inhibitors are...

Redefining complex PCI: impact of real-world data and novel evidence on IV antithrombotic strategies

Integrating the newest valve guidelines into daily clinical reality

12 Sep 2025 – From PCR Rio Valves 2025

Integrate the 2025 EACTS valve guidelines into your clinical practice with a focus on valvular heart disease management tailored to Latin American realities. This session reviews the most relevant updates on aortic stenosis management and transcatheter approaches for mitral and tricuspid valves.

Watch the interview with Fabien...

Integrating the newest valve guidelines into daily clinical reality

Learning from lived experience and contemporary evidence: shaping the treatment of women with heart valve disease

17 Nov 2025 – From PCR London Valves 2025

This session provides an in-depth exploration of the lived experiences of women with valvular heart disease, emphasizing the unique challenges in detection, diagnosis, treatment, and follow-up. It integrates contemporary evidence and the forthcoming 2025 ESC/EACTS guidelines to offer practice-ready strategies tailored to the management of valvular...

Future devices for structural heart interventions

08 Feb 2025 – From PCR Tokyo Valves 2025

Get a glimpse into the future of structural heart interventions! This PCR Tokyo Valves 2025 session dives into the latest innovations in imaging and explores groundbreaking devices for mitral and tricuspid valve treatments. Watch as experts discuss how these advancements are set to reshape clinical practice.

Future devices for structural heart interventions

Supraflex for high-risk patients and lesions: from practice to evidence-based medicine proven through FIRE and COMPARE

20 May 2025 – From EuroPCR 2025

Discover the latest evidence on the Supraflex thin-strut sirolimus DES in complex cases—from small vessels and diabetes to STEMI—supported by OCT analysis. This session highlights Supraflex’s performance in high bleeding risk and elderly patients, featuring data from FIRE, COMPARE, EARTH HBR, and Cruz Senior studies. Get...

Supraflex for high-risk patients and lesions: from practice to evidence-based medicine proven through FIRE and COMPARE

Highlights in valvular heart disease research - The year in EuroIntervention

17 Nov 2025 – From PCR London Valves 2025

This session highlights the most impactful research in valvular heart disease published in EuroIntervention in 2025. It reviews pivotal studies such as the ASCoP registry on complex PCI in severe aortic stenosis, the LANDMARK trial comparing Myval THV to other valves, and the D-PACE scoring system...

Symplicity Spyral renal denervation: more insights from clinical practice

21 May 2025 – From EuroPCR 2025

Renal denervation is gaining momentum in the management of hypertension. This EuroPCR 2025 session brings together long-term clinical experience and practical guidance on using the Symplicity Spyral™ system. Learn how to apply the latest European guidelines in daily practice, pick up valuable procedural tips from over...

Symplicity Spyral renal denervation: more insights from clinical practice

Pulmonary embolism - What should we do in the cathlab?

22 May 2025 – From EuroPCR 2025

Explore this session focused on pulmonary embolism management in the cathlab, highlighting when pharmacotherapy is insufficient and reviewing interventional options anticipated in 2025. Engage with real cases including polytrauma with acute respiratory failure and complex presentations like pre-syncope and scoliosis, accompanied by expert discussions and key...

Pulmonary embolism - What should we do in the cathlab?

How complex left main intervention can be?

21 May 2025 – From EuroPCR 2025

Stay updated on the complexities of left main coronary artery interventions with this comprehensive session. Delve into the latest guidelines and trial data for 2025, understand the meticulous preparation and advanced techniques involved, and examine potential adverse effects and complications through real-world complex case scenarios.

How complex left main intervention can be?
Didn’t find what you were looking for?